Civik Thomas 4
4 · FIVE PRIME THERAPEUTICS, INC. · Filed Apr 13, 2021
Insider Transaction Report
Form 4
Civik Thomas
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2021-04-09$37.94/sh−11,088$420,679→ 68,971 total
Footnotes (1)
- [F1]Includes 3,859 shares acquired on November 15, 2020 and 1,200 shares acquired on April 1, 2021, in each case, pursuant to Five Prime Therapeutics, Inc.'s 2013 Employee Stock Purchase Plan.